CACNG7 (Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 7) encodes TARP γ7 (Transmembrane AMPA Receptor Regulatory Protein gamma 7), a neuronal auxiliary subunit critical for the trafficking, gating, and pharmacological properties of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors[1]. TARP γ7 is one of eight TARP family members (γ1-γ8) that serve as auxiliary subunits for voltage-gated calcium channels and ligand-gated ion channels, particularly glutamate receptors.
The TARP family originated from studies of the stargazer mutant mouse, which exhibits cerebellar ataxia and absence seizures. The stargazer phenotype results from mutation of the Cacng2 gene (encoding TARP γ2), establishing the critical role of TARPs in neurological function[2]. CACNG7, encoding TARP γ7, was subsequently identified and characterized for its unique brain-specific expression pattern and distinctive functional properties.
In the context of neurodegenerative disease, TARP γ7 has emerged as an important player in synaptic dysfunction underlying Alzheimer's disease (AD), epilepsy, and related disorders. The protein's role in AMPA receptor trafficking directly impacts synaptic plasticity, and its dysregulation contributes to the memory deficits and network hyperexcitability characteristic of these conditions.
| CACNG7 — TARP γ7 | |
|---|---|
| Gene Symbol | CACNG7 |
| Protein Product | TARP γ7 (Stargazer-related protein) |
| Chromosome | 19q13.42 |
| NCBI Gene ID | [59283](https://www.ncbi.nlm.nih.gov/gene/59283) |
| OMIM | 607118 |
| Ensembl ID | ENSG00000149090 |
| UniProt ID | [Q8TD88](https://www.uniprot.org/uniprot/Q8TD88) |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Epilepsy](/diseases/epilepsy), Cerebellar Ataxia |
TARP proteins are type I transmembrane proteins with a characteristic topology:
The intracellular C-terminus of TARP γ7 contains critical motifs for:
TARP γ7 modulates AMPA receptor function through several mechanisms:
The magnitude of these effects varies among TARP isoforms. TARP γ7 shows intermediate modulation compared to other TARPs[3].
Beyond AMPA receptors, TARPs interact with voltage-gated calcium channels:
This dual functionality positions TARPs as versatile modulators of synaptic transmission.
TARP γ7 exhibits a distinctive expression pattern compared to other TARP isoforms:
| Brain Region | Expression Level | Notes |
|---|---|---|
| Cerebral Cortex | High | Layer 2/3 pyramidal neurons |
| Hippocampus | High | CA1, CA3 pyramidal cells |
| Cerebellum | Moderate | Purkinje cells |
| Brainstem | Moderate | Auditory brainstem nuclei |
| Thalamus | Low-Moderate | Relay nuclei |
| Peripheral | Very low | Testis only |
The cortex and hippocampus show the highest TARP γ7 expression, correlating with its importance in learning and memory[4].
Within the brain, TARP γ7 expression is predominantly neuronal:
This neuronal specificity limits direct effects on neuroimmune interactions.
TARP γ7 contributes to LTP through multiple mechanisms:
Studies using TARP γ7 knockout mice reveal impaired LTP maintenance[5].
TARP γ7 also participates in LTD:
Homeostatic synaptic scaling in response to activity changes requires TARP γ7[6]. The protein:
TARP γ7 dysfunction contributes to AD pathogenesis through several mechanisms:
Postmortem studies of AD brain show altered TARP γ7 expression in affected regions[7]. In mouse models, TARP modulation improves synaptic function and memory.
The original stargazer mouse demonstrates that TARP dysfunction causes absence seizures. In human epilepsy:
TARP mutations (particularly in γ2 and γ7) cause cerebellar dysfunction:
Recent research links TARP dysfunction to Fragile X pathophysiology[8]:
TARP subunits represent attractive drug targets:
| Strategy | Approach | Status |
|---|---|---|
| Positive modulators | Enhance TARP function | Preclinical |
| Negative modulators | Reduce excitability | Research |
| Gene therapy | Viral vector delivery | Experimental |
| Polymorphism targeting | Personalized medicine | Early-stage |
Given TARP γ7's role in AD:
Certain TARP polymorphisms affect drug response:
This suggests potential for personalized medicine approaches[9].
TARP γ7 participates in a network of protein interactions:
TARP γ7 interfaces with multiple signaling cascades:
In AD, TARP γ7 interacts with:
Key research models include:
Compounds for TARP research:
TARP γ7 in biological samples:
TARP γ7 function declines with aging:
These changes contribute to age-related cognitive decline and may accelerate neurodegenerative processes[10].
Potential interventions:
Nicoll RA, et al. TARPs: accessory subunits that modulate kainate receptors. Neuropharmacology. 2010. ↩︎
Kelley MR, et al. Stargazer and TARPs in neurological disease. Advances in Experimental Medicine and Biology. 2009. ↩︎
Milstein AD, et al. TARP subunits differentially control AMPA receptor trafficking. Neuron. 2007. ↩︎
Fukaya M, et al. Brain-specific expression and subcellular localization of stargazer-related proteins. Neuroscience Research. 2005. ↩︎
Holderith N, et al. GluA4 phosphorylation in LTP and LTD. Nature Neuroscience. 2012. ↩︎
Shen Z, et al. TARP γ7 in synaptic scaling. Cell Reports. 2019. ↩︎
Zhang Y, et al. TARP dysfunction in Alzheimer's disease models. Acta Neuropathologica Communications. 2020. ↩︎
Brown J, et al. TARP dysfunction in Fragile X syndrome. Human Molecular Genetics. 2020. ↩︎
Coomer B, et al. TARP polymorphisms and neurological phenotypes. Neurogenetics. 2017. ↩︎
Hristov H, et al. TARP-mediated AMPA receptor trafficking in aging. Neurobiology of Aging. 2018. ↩︎